Emerald Group Publishing Limited
Copyright © 2004, Emerald Group Publishing Limited
Earlier trial showed 63 per cent reduction in prostate cancer
In an earlier trial researchers at Cornell University and the University of Arizona reported a 63 per cent reduction in the development of prostate cancer in men who had taken a 200-microgram-per-day selenium supplement for ten years compared to men who took a placebo.
Selenium is a powerful antioxidant and neutralises free radicals. It enhances the P450 enzyme which detoxifies some carcinogens. Selenium proteins themselves are also involved in the repair of damaged DNA.